Digging into Digoxin: An Evidence-Based Review of Its Role in Past and Present Therapy

Newark, DE US

March 27, 2026

Digoxin, a cardiac glycoside, is often used when first-line agents are ineffective for treating heart failure and atrial fibrillation. While digoxin was historically a popular treatment option for heart failure, concerns over its efficacy and safety have limited its use in the present day.

This activity will provide essential knowledge of digoxin, including its indications, mechanism of action, pharmacokinetics, and a review of the current evidence to foster well-informed decisions and enhance the overall management of digoxin. This will include an interactive component where participants will complete knowledge checks to assess their learning throughout the activity.

Target Audience

Pharmacists
Pharmacy Technicians
Other Healthcare Professionals

Learning Objectives

At the conclusion of this activity, Pharmacists should be able to:

Describe the mechanism of action, pharmacokinetic properties, and therapeutic serum concentration range of digoxin.
Evaluate the evidence supporting or opposing digoxin use for symptom reduction in HF and rate control in AF.
Apply current clinical practice guidelines to determine appropriate patient selection, dosing, and monitoring of digoxin in HF and AF.

At the conclusion of this activity, pharmacy technicians should be able to:

Identify available dosage forms, strengths, and routes of administration of digoxin
Recognize digoxin as a high-alert medication and apply appropriate verification steps during medication preparation
Describe when to escalate potential discrepancies or concerns related to digoxin to the pharmacist

Course summary

Available credit:

1.00 ACPE Pharmacist
1.00 ACPE Pharmacy Technician

Course opens:

03/27/2026

Course expires:

05/26/2026

Event starts:

03/27/2026 - 12:00pm CDT

Event ends:

03/27/2026 - 1:00pm CDT

Add to calendar:

Newark Campus Ammon Back Auditorium

4755 Ogletown -Stanton Road

Newark, DE 19718

United States

FACULTY & PLANNERS

Faculty

Huelena Nguyen, PharmD

Pharmacy Resident

ChristianaCare

Planning Committee

Huelena Nguyen, PharmD

Pharmacy Resident

ChristianaCare

Brandi Steady, PharmD

Clinical Pharmacist

ChristianaCare

Marilu Kelly, MSN, RN, NPD-BC, CHCP

Director, Continuing Education

Vizient, Inc.

Kim Bentley, CHCP

CE Programs Manager

Vizient, Inc.

DISCLOSURE

As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.

Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.

Disclosure Statements

Absence of Relevant Financial Relationships

None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Statement of Content Validity

Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.

FDA Off-Label Use

Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.

Disclaimer

The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.

Planner(s)